HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print August 1, 2003

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0303116v1 74/5/868    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jing, H. Articles by Ganea, D. Search for Related Content PubMed PubMed Citation Articles by Jing, H. Articles by Ganea, D.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0303116

Received for publication March 24, 2003.
Revised July 8, 2003.
Accepted for publication July 9, 2003.

Article

Prostaglandin E2 Inhibits Production of the Inflammatory Chemokines CCL3 and CCL4 in Dendritic Cells

Department of Biological Sciences, Rutgers University, Newark, NJ 07102

^@ To whom correspondence should be addressed. E-mail: dganea{at}andromeda.rutgers.edu.

	Abstract

Dendritic cells bridge innate and adaptive immunity and participate in both responses. Upon capture of pathogens, dendritic cells release inflammatory cytokines and chemokines, attracting other immune cells to the infection site. Anti-inflammatory cytokines, glucocorticoids, anti-inflammatory neuropeptides, and lipid mediators such as prostaglandin E2 (PGE₂) limit and control the inflammatory response. In this study we report that exogenous PGE₂ inhibits CCL3 (MIP-1) and CCL4 (MIP-1) expression and release from dendritic cells stimulated with either lipopolysaccharide (LPS), a TLR4 ligand, or peptidoglycan, a TLR2 ligand. The inhibition is dose-dependent and occurs at both the mRNA and protein levels. The inhibitory effect is mediated through EP2 and EP4 receptors and requires the presence of PGE₂ at the time of LPS stimulation. Intraperitoneal administration of PGE₂ together with LPS results in a reduction in the levels of CCL3 and CCL4 released in the peritoneal fluid, a reduction in the number of dendritic cells accumulating in the peritoneal cavity, and a reduction in CCL3 amount per cell in the peritoneal cell population. These results suggest that one of the mechanisms by which endogenous PGE₂ acts as an anti-inflammatory agent, is the inhibition of inflammatory chemokine release from activated dendritic cells, preventing the excess accumulation of activated immune cells.

Key Words: lipid mediators • inflammation • bone marrow-derived dendritic cells

This article has been cited by other articles:

				E S Molloy, M P Morgan, G A Doherty, B McDonnell, J O'Byrne, D J Fitzgerald, and G M McCarthy Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2 Ann Rheum Dis, December 1, 2008; 67(12): 1773 - 1779. [Abstract] [Full Text] [PDF]

				T. Khayrullina, J.-H. Yen, H. Jing, and D. Ganea In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells J. Immunol., July 1, 2008; 181(1): 721 - 735. [Abstract] [Full Text] [PDF]

				X. J. Xu, J. S. Reichner, B. Mastrofrancesco, W. L. Henry Jr., and J. E. Albina Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-{beta} Production J. Immunol., February 15, 2008; 180(4): 2125 - 2131. [Abstract] [Full Text] [PDF]

				J.-H. Yen, T. Khayrullina, and D. Ganea PGE2-induced metalloproteinase-9 is essential for dendritic cell migration Blood, January 1, 2008; 111(1): 260 - 270. [Abstract] [Full Text] [PDF]

				L.-K. Sun, T. Reding, M. Bain, M. Heikenwalder, D. Bimmler, and R. Graf Prostaglandin E2 modulates TNF-{alpha}-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1196 - G1204. [Abstract] [Full Text] [PDF]

				A. F. Sheibanie, J.-H. Yen, T. Khayrullina, F. Emig, M. Zhang, R. Tuma, and D. Ganea The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23->IL-17 Axis J. Immunol., June 15, 2007; 178(12): 8138 - 8147. [Abstract] [Full Text] [PDF]

				F. Kamachi, H. S. Ban, N. Hirasawa, and K. Ohuchi Inhibition of Lipopolysaccharide-Induced Prostaglandin E2 Production and Inflammation by the Na+/H+ Exchanger Inhibitors J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 345 - 352. [Abstract] [Full Text] [PDF]

				R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy IV, K. F. Roby, and R. B.S. Roden CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells. Cancer Res., July 1, 2006; 66(13): 6807 - 6815. [Abstract] [Full Text] [PDF]

				D. Wang, H. Wang, J. Brown, T. Daikoku, W. Ning, Q. Shi, A. Richmond, R. Strieter, S. K. Dey, and R. N. DuBois CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer J. Exp. Med., April 17, 2006; 203(4): 941 - 951. [Abstract] [Full Text] [PDF]

				D Wang and R N DuBois PROSTAGLANDINS AND CANCER Gut, January 1, 2006; 55(1): 115 - 122. [Full Text] [PDF]

				M. Zeyda, M. D. Saemann, K. M. Stuhlmeier, D. G. Mascher, P. N. Nowotny, G. J. Zlabinger, W. Waldhausl, and T. M. Stulnig Polyunsaturated Fatty Acids Block Dendritic Cell Activation and Function Independently of NF-{kappa}B Activation J. Biol. Chem., April 8, 2005; 280(14): 14293 - 14301. [Abstract] [Full Text] [PDF]

				H. Jing, J.-H. Yen, and D. Ganea A Novel Signaling Pathway Mediates the Inhibition of CCL3/4 Expression by Prostaglandin E2 J. Biol. Chem., December 31, 2004; 279(53): 55176 - 55186. [Abstract] [Full Text] [PDF]

				E. Vassiliou, V. Sharma, H. Jing, F. Sheibanie, and D. Ganea Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells J. Immunol., December 1, 2004; 173(11): 6955 - 6964. [Abstract] [Full Text] [PDF]